What's new in the IGF-binding proteins?

Growth Hormone and IGF Research

Volumn 14, Issue 5, 2004, Pages 329-336

  Rosenzweig, Steven A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Binding site; IGF binding protein (IGFBP); IGF I receptor (IGF IR); Insulin like growth factor (IGF); Structure function

Indexed keywords

CELL SURFACE RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; BIOTINYLATION; BREAST CANCER; CANCER RISK; CARCINOGENICITY; CELL MIGRATION; CELL TRANSPORT; CELL TYPE; COLORECTAL CANCER; GENETIC CONSERVATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BINDING SITES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT;

EID: 4444300675     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2004.02.003     Document Type: Review

References (90)

1. Hwa V. Oh Y. Rosenfeld R.G. The insulin-like growth factor-binding protein (IGFBP) superfamily Endocr. Rev. 20 1999 761-787
2. Clemmons D.R. Use of mutagenesis to probe IGF-binding protein structure/function relationships Endocr. Rev. 22 2001 800-817
3. Baxter R.C. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities Am. J. Physiol. Endocrinol. Metab. 278 2000
4. Firth S.M. Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins Endocr. Rev. 23 2002 824-854
5. Forbes B.E. Turner D. Hodge S.J. McNeil K.A. Forsberg G. Wallace J.C. Localization of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain J. Biol. Chem. 273 1998 4647-4652
6. Lalou C. Lassarre C. Binoux M. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin Endocrinology 137 1996 3206-3212
7. Qin X. Strong D.D. Baylink D.J. Mohan S. Structure-function analysis of the human insulin-like growth factor binding protein-4 J. Biol. Chem. 273 1998 23509-23516
8. Spencer E.M. Chan K. A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3 Prog. Growth Factor Res. 6 1995 209-214
9. Brinkman A. Kortleve D.J. Schuller A.G. Zwarthoff E.C. Drop S.L. Site-directed mutagenesis of the NH2-terminal region of IGF binding protein 1; analysis of IGF binding capability FEBS Lett. 291 1991 264-268
10. Kalus W. Zweckstetter M. Renner C. et al. Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions EMBO J. 17 1998 6558-6572
11. Zeslawski W. Beisel H.G. Kamionka M. et al. The interaction of insulin-like growth factor-I with the NH2-terminal domain of IGFBP-5 EMBO J. 20 2001 3638-3644
12. Imai Y. Moralez A. Andag U. Clarke J.B. Busby W.H.Jr. Clemmmons D.R. Substitutions for hydrophobic amino acids in the NH2-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions J. Biol. Chem. 275 2000 18188-18194
13. Buckway C.K. Wilson E.M. Ahlsen M. Bang P. Oh Y. Rosenfeld R.G. Mutation of three critical amino acids of the NH2-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding J. Clin. Endocrinol. Metab. 86 2001 4943-4950
14. Hong J. Zhang G. Dong F. Rechler M.M. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells J. Biol. Chem. 277 2002 10489-10497
15. Ho P.J. Baxter R.C. Characterization of truncated insulin-like growth factor-binding protein-2 in human milk Endocrinology 138 1997 3811-3818
16. Vorwerk P. Yamanaka Y. Spagnoli A. Oh Y. Rosenfeld R.G. Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine J. Clin. Endocrinol. Metab. 83 1998 1392-1395
17. Carrick F.E. Forbes B.E. Wallace J.C. BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino- and carboxyl-terminal domains J. Biol. Chem. 276 2001 27120-27128
18. Standker L. Braulke T. Mark S. et al. Partial IGF affinity of circulating NH2- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain Biochemistry 39 2000 5082-5088
19. Horney M.J. Evangelista C.A. Rosenzweig S.A. Synthesis and characterization of insulin-like growth factor (IGF)-1 photoprobes selective for the IGF-binding proteins (IGFBPS). Photoaffinity labeling of the IGF-binding domain on IGFBP-2 J. Biol. Chem. 276 2001 2880-2889
20. Wang J.F. Hampton B. Mehlman T. Burgess W.H. Rechler M.M. Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors Biochem. Biophys. Res. Commun. 157 1988 718-726
21. Devi G.R. Yang D.H. Rosenfeld R.G. Oh Y. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling Endocrinology 141 2000 4171-4179
22. Galanis M. Firth S.M. Bond J. et al. Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3 J. Endocrinol. 169 2001 123-133
23. Vorwerk P. Hohmann B. Oh Y. Rosenfeld R.G. Shymko R.M. Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 NH2- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor Endocrinology 143 2002 1677-1685
24. Payet L.D. Wang X.H. Baxter R.C. Firth S.M. Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions Endocrinology 144 2003 2797-2806
25. Kibbey M.M. Jameson M.J. Rosenzweig S.A. Structural and functional analysis of the IGF binding proteins (IGFBPs): cleavage of IGFBP-2 and IGFBP-3 with the tryptophan-selective agent, BNPS-skatole Endocrinology 2003
26. Kibbey M.M. Jameson M.J. Rosenzweig S.A. Structural and functional analysis of the IGF Binding Proteins (IGFBPs): Cleavage of IGFBP-2 and IGFBP-3 with the tryptophan-selective agent, BNPS-skatole Endocrinology 144 2003 226A
27. Hossenlopp P. Seurin D. Segovia-Quinson B. Hardouin S. Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies Anal. Biochem. 154 1986 138-143
28. Fowlkes J.L. Serra D. A rapid, non-radioactive method for the detection of insulin-like growth factor binding proteins by Western ligand blotting Endocrinology 137 1996 5751-5754
29. Op De Beeck L. Verlooy J.E. Van Buul-Offers S.C. Du Caju M.V. Detection of serum insulin-like growth factor binding proteins on Western ligand blots by biotinylated IGF and enhanced chemiluminescence J. Endocrinol. 154 1997 R1-R5
30. Grulich-Henn J. Spiess S. Heinrich U. Schonberg D. Bettendorf M. Ligand blot analysis of insulin-like growth factor-binding proteins using biotinylated insulin-like growth factor-I Horm. Res. 49 1998 1-7
31. Robinson S.A. Rosenzweig S.A. Synthesis and characterization of biotinylated forms of Insulin-like growth factor-1: Insights into the interaction of IGF-1 with IGFBP-2 and IGFBP-3 Endocrinology 144 2003 225A
32. S.A. Robinson, S.A. Rosenzweig, Synthesis and characterization of biotinylated forms of insulin like growth factor 1 (IGF-1): Topographical evaluation of the IGF-1: IGFBP-2 and IGFBP-3 interface (2004), submitted
33. Rechler M.M. Growth inhibition by insulin-like growth factor (IGF) binding protein-3 - what's IGF got to do with it? Endocrinology 138 1997 2645-2647
34. Jones J.I. Gockerman A. Busby Jr. W.H. Wright G. Clemmons D.R. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence Proc. Natl. Acad. Sci. USA 90 1993 10553-10557
35. Yee D. The insulin-like growth factor system as a treatment target in breast cancer Semin. Oncol. 29 2002 86-95
36. Arai T. Busby Jr. W. Clemmons D.R. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix Endocrinology 137 1996 4571-4575
37. Russo V.C. Rekaris G. Baker N.L. Bach L.A. Werther G.A. Basic fibroblast growth factor induces proteolysis of secreted and cell membrane-associated insulin-like growth factor binding protein-2 in human neuroblastoma cells Endocrinology 140 1999 3082-3090
38. Russo V.C. Bach L.A. Fosang A.J. Baker N.L. Werther G.A. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb Endocrinology 138 1997 4858-4867
39. Russo V.C. Bach L.A. Werther G.A. Cell membrane association of insulin-like growth factor binding protein-2 (IGFBP-2) in the rat brain olfactory bulb Prog. Growth Factor Res. 6 1995 329-336
40. Hoeflich A. Reisinger R. Vargas G.A. et al. Mutation of the RGD sequence does not affect plasma membrane association and growth inhibitory effects of elevated IGFBP-2 in vivo FEBS Lett. 523 2002 63-67
41. Zhang X. Yee D. Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility Cancer Res. 62 2002 4369-4375
42. Dong F. Wu H.B. Hong J. Rechler M.M. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells J. Cell. Physiol. 190 2002 63-73
43. Schneider M.R. Lahm H. Wu M. Hoeflich A. Wolf E. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins FASEB J. 14 2000 629-640
44. Valentinis B. Bhala A. DeAngelis T. Baserga R. Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene Mol. Endocrinol. 9 1995 361-367
45. Oh Y. Muller H.L. Ng L. Rosenfeld R.G. Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action J. Biol. Chem. 270 1995 13589-13592
46. Rajah R. Valentinis B. Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism J. Biol. Chem. 272 1997 12181-12188
47. Oh Y. Muller H.L. Lamson G. Rosenfeld R.G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition J. Biol. Chem. 268 1993 14964-14971
48. Gill Z.P. Perks C.M. Newcomb P.V. Holly J.M. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner J. Biol. Chem. 272 1997 25602-25607
49. Spoerri P.E. Caballero S. Wilson S.H. Shaw L.C. Grant M.B. Expression of IGFBP-3 by human retinal endothelial cell cultures: IGFBP-3 involvement in growth inhibition and apoptosis Invest. Ophthalmol. Vis. Sci. 44 2003 365-369
50. Berfield A.K. Andress D.L. Abrass C.K. IGFBP-5 (201-218) stimulates Cdc42GAP aggregation and filopodia formation in migrating mesangial cells Kidney Int. 57 2000 1991-2003
51. Abrass C.K. Berfield A.K. Andress D.L. Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration Am. J. Physiol. 273 1997 F899-F906
52. Miyakoshi N. Richman C. Kasukawa Y. Linkhart T.A. Baylink D.J. Mohan S. Evidence that IGF-binding protein-5 functions as a growth factor J. Clin. Invest. 107 2001 73-81
53. Andress D.L. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor Am. J. Physiol. 274 1998 E74-E750
54. Andress D.L. IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice Am. J. Physiol. Endocrinol. Metab. 281 2001
55. Perks C.M. McCaig C. Clarke J.B. Clemmons D.R. Holly J.M. Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells Biochem. Biophys. Res. Commun. 294 2002 995-1000
56. Perks C.M. McCaig C. Clarke J.B. Clemmons D.R. Holly J.M. A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells Biochem. Biophys. Res. Commun. 294 2002 988-994
57. Schedlich L.J. Young T.F. Firth S.M. Baxter R.C. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells J. Biol. Chem. 273 1998 18347-18352
58. Schedlich L.J. Le Page S.L. Firth S.M. Briggs L.J. Jans D.A. Baxter R.C. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit J. Biol. Chem. 275 2000 23462-23470
59. Butt A.J. Fraley K.A. Firth S.M. Baxter R.C. IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells Endocrinology 143 2002 2693-2699
60. Lee K.W. Cohen P. Nuclear effects: unexpected intracellular actions of insulin-like growth factor binding protein-3 J. Endocrinol. 175 2002 33-40
61. Ikonen M. Liu B. Hashimoto Y. et al. Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis Proc. Natl. Acad. Sci. USA 100 2003 13042-13047
62. Xu Q. Yan B. Li S. Duan C. Fibronectin binds insulin-like growth factor binding protein (IGFBP)-5 and abolishes its ligand-dependent action on cell migration J. Biol. Chem. 2003
63. Yamanaka Y. Fowlkes J.L. Wilson E.M. Rosenfeld R.G. Oh Y. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule Endocrinology 140 1999 1319-1328
64. Knudtson K.L. Boes M. Sandra A. Dake B.L. Booth B.A. Bar R.S. Distribution of chimeric IGF binding protein (IGFBP)-3 and IGFBP-4 in the rat heart: importance of C-terminal basic region Endocrinology 142 2001 3749-3755
65. Leal S.M. Huang S.S. Huang J.S. Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-beta receptor in mink lung epithelial cells J. Biol. Chem. 274 1999 6711-6717
66. Huang S.S. Ling T.Y. Tseng W.F. et al. Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1 FASEB J. 17 2003 2068-2081
67. LeRoith D. Roberts Jr. C.T. The insulin-like growth factor system and cancer Cancer Lett. 195 2003 127-137
68. Lee H.Y. Chun K.H. Liu B. et al. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer Cancer Res. 62 2002 3530-3537
69. Fuller G.N. Rhee C.H. Hess K.R. et al. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling Cancer Res. 59 1999 4228-4232
70. Wang H. Shen W. Huang H. et al. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes Cancer Res. 63 2003 4315-4321
71. Allander S.V. Illei P.B. Chen Y. et al. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation Am. J. Pathol. 161 2002 1587-1595
72. Sallinen S.L. Sallinen P.K. Haapasalo H.K. et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques Cancer Res. 60 2000 6617-6622
73. Bubendorf L. Kolmer M. Kononen J. et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays J. Natl. Cancer Inst. 91 1999 1758-1764
74. Moore M.G. Wetterau L.A. Francis M.J. Peehl D.M. Cohen P. Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells Int. J. Cancer 105 2003 14-19
75. Hoeflich A. Reisinger R. Lahm H. et al. Insulin-like growth factor-binding protein2 in tumorigenesis: protector or promoter? Cancer Res. 61 2001 8601-8610
76. Horney M.J. Shirley D.W. Kurtz D.T. Rosenzweig S.A. Elevated glucose increases mesangial cell sensitivity to insulin-like growth factor I Am. J. Physiol. 274 1998 F1045-F1053
77. Smith L.E. Shen W. Perruzzi C. et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor Nat. Med. 5 1999 1390-1395
78. M.G. Slomiany, S.A. Rosenzweig, Autocrine effects of IGF-I induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19. Am J Physiol: Cell Physiol (2004) Submitted
79. M.G. Slomiany, S.A. Rosenzweig, IGF-I Induced VEGF and IGFBP-3 secretion correlates with increased HIF-1-a nuclear translocation in the retinal pigment epithelial cell line D407. Invest Ophthalmol & Vis Sci (2004) Submitted
80. Deshayes K. Schaffer M.L. Skelton N.J. Nakamura G.R. Kadkhodayan S. Sidhu S.S. Rapid identification of small binding motifs with high-throughput phage display: discovery of peptidic antagonists of IGF-I function Chem. Biol. 9 2002 495-505
81. Schaffer M.L. Deshayes K. Nakamura G. Sidhu S. Skelton N.J. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I Biochemistry 42 2003 9324-9334
82. Loddick S.A. Liu X.J. Lu Z.X. et al. Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke Proc. Natl. Acad. Sci. USA 95 1998 1894-1898
83. Lowman H.B. Chen Y.M. Skelton N.J. et al. Molecular mimics of insulin-like growth factor 1 (IGF-I) for inhibiting IGF-I: IGF-binding protein interactions Biochemistry 37 1998 8870-8878
84. Sakai K. Lowman H.B. Clemmons D.R. Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture J. Biol. Chem. 277 2002 13620-13627
85. Chen C. Zhu Y.F. Liu X.J. Lu Z.X. Xie Q. Ling N. Discovery of a series of nonpeptide small molecules that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins J. Med. Chem. 44 2001 4001-4010
86. Mackay K.B. Loddick S.A. Naeve G.S. Vana A.M. Verge G.M. Foster A.C. Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo J. Cereb. Blood Flow Metab. 23 2003 1160-1167
87. Kamionka M. Rehm T. Beisel H.G. Lang K. Engh R.A. Holak T.A. In silico and NMR identification of inhibitors of the IGF-I and IGF-binding protein-5 interaction J. Med. Chem. 45 2002 5655-5660
88. Shand J.H. Beattie J. Song H. et al. Specific amino acid substitutions determine the differential contribution of the NH2- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I J. Biol. Chem. 278 2003 17859-17866
89. Hobba G.D. Lothgren A. Holmberg E. Forbes B.E. Francis G.L. Wallace J.C. Alanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding J. Biol. Chem. 273 1969 19691-19698
90. Cooke R.M. Harvey T.S. Campbell I.D. Solution structure of human insulin-like growth factor1: a nuclear magnetic resonance and restrained molecular dynamics study Biochemistry 30 1991 5484-5491